Selected peer-reviewed publications by Sophia Magkouta
Magkouta SF, Vaitsi PC, Pappas AG, Iliopoulou M, Kosti CN, Psarra K, Kalomenidis IT. CSF1/CSF1R Axis Blockade Limits Mesothelioma and Enhances Efficiency of Anti-PDL1 Immunotherapy.
Cancers (Basel). 2021; 13(11):2546. doi: 10.3390/cancers13112546.
Magkouta SF, Pappas AG, Vaitsi PC, Agioutantis PC, Pateras IS, Moschos CA, Iliopoulou MP, Kosti CN, Loutrari HV, Gorgoulis VG, Kalomenidis IT. MTH1 favors mesothelioma progression and mediates paracrine rescue of bystander endothelium from oxidative damage.
JCI Insight. 2020 18;5(12):e134885. doi:10.1172/jci.insight.134885.
Giopanou I, Kanellakis NI, Giannou AD, Lilis I, Marazioti A, Spella M, Papaleonidopoulos V, Simoes DCM, Zazara DE, Agalioti T, Moschos C, Magkouta S, Kalomenidis I, Panoutsakopoulou V, Lamort AS, Stathopoulos GT, Psallidas I. Osteopontin drives KRAS-mutant lung adenocarcinoma.
Carcinogenesis. 2019 Nov 19. pii: bgz190. doi: 10.1093/carcin/bgz190.
Kerdidani D, Magkouta S, Tsoumakidou M. Emphysema assessment for personalized immunotherapy response prediction in lung cancer patients.
J Thorac Dis. 2019; 11(Suppl 15):S2034-S2035. doi: 10.21037/jtd.2019.08.98.
Apostolos G. Pappas, Sophia Magkouta , Ioannis S. Pateras, Ioannis Skianis, Charalampos Moschos, Maria Eleni Vazakidou, Katherina Psarra, Vassilis G. Gorgoulis & Ioannis Kalomenidis Versican modulates tumor-associated macrophage properties to stimulate mesothelioma growth
OncoImmunology 2019, 8:2, DOI: 10.1080/2162402X.2018.1537427
Magkouta S, Kollintza A, Moschos C, Spella M, Skianis I, Pappas A, Vazakidou ME, Stathopoulos G, Kalomenidis I. Role of angiopoietins in mesothelioma progression.
Cytokine. 2018 pii: S1043-4666(18)30341-7. doi: 10.1016/j.cyto.2018.08.006.
Kerdidani D, Magkouta S, Chouvardas P, Karavana V, Glynos K, Roumelioti F, Zakynthinos S, Wauters E, Janssens W, Lambrechts D, Kollias G, Tsoumakidou M. Cigarette Smoke-Induced Emphysema Exhausts Early Cytotoxic CD8+ T Cell Responses against Nascent Lung Cancer Cells.
J Immunol. 2018 Sep 1;201(5):1558-1569. doi: 10.4049/jimmunol.1700700.
Magkouta S, Pappas A, Pateras IS, Kollintza A, Moschos C, Vazakidou ME, Karavana V, Gorgoulis VG, Kalomenidis I. Targeting Tie-2/angiopoietin axis in experimental mesothelioma confers differential responses and raises predictive implications.
Oncotarget. 2018 24;9(31):21783-21796. doi: 10.18632/oncotarget.25004.
Magkouta S, Pappas A, Moschos C, Vazakidou ME, Psarra K, Kalomenidis I. Oncotarget. Icmt inhibition exerts anti-angiogenic and anti-hyperpermeability activities impeding malignant pleural effusion.
2016 doi: 10.18632/oncotarget.7912.
Vazakidou ME, Magkouta S, Moschos C, Psallidas I, Pappas A, Psarra K, Kalomenidis I. Temsirolimus targets multiple hallmarks of cancer to impede mesothelioma growth in vivo.
Respirology. 2015 Aug 5.
Skouras VS, Magkouta S, Psallidas I, Tsilioni I, Maragozidis P, Gourgoulianis KI, Kalomenidis I. Interleukin-27 improves the ability of adenosine deaminase to rule out tuberculous pleural effusion regardless of pleural tuberculosis prevalence.
Infect Dis (Lond). 2015 Jul;47(7):477-83.
Kouritas VK, Magkouta S, Zisis C, Psallidas I, Gourgoulianis KI, Kalomenidis I. Paracetamol and ibuprofen block hydrothorax absorption in mice
†Eur J Cardiothorac Surg. 2015 Mar;47(3):426-30
Vazakidou ME, Magkouta S, Moschos C, Kalomenidis I. Mammalian target of rapamycin (mTOR) inhibition does not prevent lung adenocarcinoma-induced malignant pleural effusion.
Respirology. 2014 19(2):290-2.
Psallidas I, Stathopoulos GT, Maniatis NA, Magkouta S, Moschos C, Karabela SP, Kollintza A, Simoes DC, Kardara M, Vassiliou S, Papiris SA, Roussos C, Kalomenidis I. Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion.
Oncogene. 2013 Jan 24;32(4):528-35.
Marazioti A, Kairi CA, Spella M, Giannou AD, Magkouta S, Giopanou I, Papaleonidopoulos V, Kalomenidis I, Snyder LA, Kardamakis D, Stathopoulos GT. Beneficial impact of CCL2 and CCL12 neutralization on experimental malignant pleural effusion.
PLoS One. 2013;8(8):71207.
Kollintza A, Magkouta S, Psallidas I, Moschos C, Stratiki M, Esquerda A, Porcel JM, Kalomenidis I. IL-17A is involved in bacteria-related acute pleural inflammation.
Respirology. 2013 Apr;18(3):488-9
Karabela SP, Kairi CA, Magkouta S, Psallidas I, Moschos C, Stathopoulos I, Zakynthinos SG, Roussos C, Kalomenidis I, Stathopoulos GT. Neutralization of tumor necrosis factor bioactivity ameliorates urethane-induced pulmonary oncogenesis in mice.
Neoplasia. 2011 Dec;13(12):1143-51.
Heleni Loutrari, Sophia Magkouta, Andreas Papapetropoulos, Charis Roussos Mastic Oil Inhibits the Metastatic Phenotype of Mouse Lung Adenocarcinoma Cells Cancers
Adenocarcinoma Cells Cancers 2011, 3(1), 789-801
Psallidas I, Karabela SP, Moschos C, Sherrill TP, Kollintza A, Magkouta S, Theodoropoulou P, Roussos C, Blackwell TS, Kalomenidis I, Stathopoulos GT. Specific effects of bortezomib against experimental malignant pleural effusion: a preclinical study.
Mol Cancer. 2010 Mar 10;9:56.
Xanthakis E, Theodosiou E, Magkouta S, Stamatis H, Loutrari H. Enzymatic transformation of flavonoids and terpenoids:structural and functional diversity of the novel derivatives.
Pure and applied chemistry A. 2010: 82, 1-16.
Magkouta S, Stathopoulos GT, Psallidas I, Papapetropoulos A, Kolisis FN, Roussos C, Loutrari H. Protective effects of mastic oil from Pistacia lentiscus variation chia against experimental growth of lewis lungcarcinoma.
Nutr Cancer. 2009;61(5):640-8.
Xanthakis E, Magkouta S, Loutrari H, Stamatis H, Roussos C, Kolisis FN. Enzymatic synthesis of perillyl alcohol derivatives and investigation of their antiproliferative activity.
Biocatalysis and Biotransformation (2009) 27 (3):170-178
Stathopoulos GT, Moschos C, Loutrari H, Kollintza A, Psallidas I, Karabela S, Magkouta S, Zhou Z, Papiris SA, Roussos C, Kalomenidis I. Zoledronic acid is effective against experimental malignant pleural effusion.
Am J Respir Crit Care Med. 2008 Jul 1;178(1):50-9.
Loutrari H, Magkouta S, Pyriochou A, Koika V, Kolisis FN, Papapetropoulos A, Roussos C. Mastic oil from Pistacia lentiscus var. chia inhibits growth and survival of human K562 leukemia cells and attenuates angiogenesis.
Nutr Cancer. 2006;55(1):86-93.